Medico Remedies MEDICO.NS · INR

Its shares trade on NSE under the ticker MEDICO.NS. It has been listed since 8 February 2018. In the fiscal year to 31 March 2026, it reported revenue of ₹2.06bn and net income of ₹131.2m. At that date it held total assets of ₹1.53bn and shareholders' equity of ₹754.7m.

Medico Remedies Ltd. engages in the manufacture, supply, and exportation of pharmaceutical drugs. The company is headquartered in Thane, Maharashtra. The company went IPO on 2018-02-08. The company is engaged in the manufacturing of medicines including Diuretics, Antimalarials, NSAIDS Tablets, Antireterovirals, Anti-Ulcer Drugs and Antacids Tablets. The company has manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements. In addition, the Company also manufactures other drugs, such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Paediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Haresh MehtaChairman of the Board, Legal Head and Chief Financial Officer, since 2017
• Ms. Vidhi ShahCompliance Officer, Company Secretary
• Mr. Harshit MehtaManaging Director, Marketing & Export Head and Executive Director, since 2011
• Mr. Rishit MehtaProduction - Technical & Quality Control Head and Whole-time Director, since 2015
• Mr. Maheshkumar DarjiAdditional Executive Director, since 2025
• Mr. Gopal JhaAdministration Manager
• Mrs. Priyal MehtaMarketing Manager
• Mr. Dushant PandeyQuality Control Manager
• Mrs. Rita MehtaNon-Executive Non-Independent Director, since 2017
• Mr. Deepesh ShahAdditional Independent Director
• Mr. Bharat RathodAdditional Non-Executive Independent Director
• Mr. Deepak VekariaAdditional Non-Executive Independent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.